UPDATED Mar 25, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RICHTER | Ft9,265.00 | -0.3% | 24.6% | Ft1.7t | Ft11,515.56 | PE10.7x | E16.9% | 4.2% | Pharmaceuticals & Biotech |